If youre struggling or considering medication once you stop breastfeeding, speak to your GP about whats safe and suitable for you
Nutritional and therapeutic potential of spirulina
[18] The practical goal isn't one hero strain it's a resilient, well-fed ecosystem
Clinical trial results discussed in this article - STEP 1 (14.9% average body weight loss with semaglutide), SURMOUNT-1 (20.9% average body weight loss with tirzepatide), and SELECT (20% reduced risk of major cardiovascular events with FDA-approved Wegovy in a specific patient population) - relate to studied active ingredients and specific FDA-approved formulations in controlled trial populations and should not be interpreted as guaranteed outcomes for any individual patient or compounded formulation
You get enhanced benefits for both skin health and overall wellness
SURMOUNT-4 The fourth study of the program, SURMOUNT-4, was designed to evaluate the efficacy of tirzepatide in weight loss maintenance in adult patients with a BMI 30 or 27 with an associated complication, but no T2D